FDA Approves PIROXICAM — Unichem Pharmaceuticals (USA), Inc.

# FDA Approves Piroxicam Generic for Unichem Pharmaceuticals Unichem Pharmaceuticals (USA), Inc. received FDA approval for its generic piroxicam oral formulation, expanding the competitive landscape in the nonsteroidal anti-inflammatory drug (NSAID) market and potentially increasing price pressure for branded alternatives. The approval of the generic version is expected to provide cost savings for patients and payers while broadening Unichem's portfolio in the established pain management segment.